IMNM

NASDAQStock$28.89-0.50 (-1.70%)
Mkt Cap 2.8BP/E Div Yield Beta 2.12Vol 369.6K
52W$8.99
$29.82

ETFs That Hold IMNM (Immunome, Inc.)

1M

+27.92%

3M

+28.15%

6M

+32.14%

YTD

+38.74%

1Y

+184.30%

3Y

+365.14%

5Y

+101.29%

ETFs That Hold IMNM

Immunome, Inc. is held by 65 ETFs. The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).

ETFFund NameWeight
ITDIiShares LifePath Target Date 2065 ETF0.00%
STSBiShares Factors US Small Blend Style ETF0.01%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
IRTRiShares LifePath Retirement ETF0.00%

Excludes leveraged and inverse ETFs.

PreviousPage 4 of 4

Frequently Asked Questions

How many ETFs hold IMNM?
Immunome, Inc. (IMNM) is held by 65 ETFs (excluding leveraged and inverse funds). The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
What is the largest ETF that holds IMNM?
By fund size, XBI (State Street SPDR S&P Biotech ETF) with $11.58B in AUM holds 0.77% of its portfolio in IMNM, representing $89.7M in market value.
What percentage of CANC is IMNM?
IMNM makes up 3.03% of CANC (Tema Oncology ETF), making it one of the largest positions in that fund.
Is IMNM in the S&P 500?
IMNM is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.